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ABSTRACT
Metazoan replication-dependent histone mRNAs are only present in S-phase, due partly to changes in their stability. These
mRNAs end in a unique stem–loop (SL) that is required for both translation and cell-cycle regulation. Previous studies
showed that histone mRNA degradation occurs through both 59/39 and 39/59 processes, but the relative contributions
are not known. The 39 end of histone mRNA is oligouridylated during its degradation, although it is not known whether this
is an essential step. We introduced firefly luciferase reporter mRNAs containing the histone 39 UTR SL (Luc-SL) and either
a normal or hDcp2-resistant cap into S-phase HeLa cells. Both mRNAs were translated, and translation initially protected
the mRNAs from degradation, but there was a lag of ~40 min with the uncleavable cap compared to ~8 min for the normal
cap before rapid decay. Knockdown of hDcp2 resulted in a similar longer lag for Luc-SL containing a normal cap, indicating
that 59/39 decay is important in this system. Inhibition of DNA replication with hydroxyurea accelerated the degradation
of Luc-SL. Knockdown of terminal uridyltransferase (TUTase) 4 but not TUTase 3 slowed the decay process, but TUTase
4 knockdown had no effect on destabilization of the mRNA by hydroxyurea. Both Luc-SL and its 59 decay intermediates
were oligouridylated. Preventing oligouridylation by 39-deoxyadenosine (cordycepin) addition to the mRNA slowed
degradation, in the presence or absence of hydroxyurea, suggesting oligouridylation initiates degradation. The spectrum
of oligouridylated fragments suggests the 39/59 degradation machinery stalls during initial degradation, whereupon
reuridylation occurs.
Keywords: hDcp2-resistant cap analog; hydroxyurea; oligouridylation; TUTase 4; cordycepin
INTRODUCTION
Histones play a critical role in eukaryotes in both packaging
chromosomal DNA and regulating gene expression at the
transcriptional level (Henikoff and Ahmad 2005; Marzluff
et al. 2008). Synthesis of the canonical replicative histones
(H2A, H2B, H3, and H4) occurs only when DNA is being
synthesized (Marzluff et al. 2008) and is regulated primarily
by changes in mRNA levels, which increase 35-fold as cells
enter S-phase. At the end of S-phase or when DNA syn-
thesis is inhibited, histone mRNAs are rapidly degraded
(Harris et al. 1991; Whitfield et al. 2000). These mRNAs are
unusual in that they contain a conserved 25- to 26-nt stem–
loop (SL) at the 39 end instead of poly(A) (Marzluff et al.
2008). The SL is recognized by a stem–loop binding protein
(SLBP) that is essential for histone pre-mRNA processing
as well as for both translation (Gallie et al. 1996; Sanchez
and Marzluff 2002) and regulated stability (Harris et al.
1991). Recent studies provide new information for a mech-
anistic model for histone mRNA degradation (Kaygun and
Marzluff 2005; Mullen and Marzluff 2008). Upon cessation
of DNA synthesis, Upf1 is recruited to the SLBP, and this,
in turn, recruits a terminal uridyltransferase (TUTase) that
catalyzes 39 oligouridylation. The oligo(U) tract forms a
binding site for the Lsm1–7 heptamer, which recruits the
machinery for decapping and bidirectional degradation of
histone mRNA by exoribonucleases.
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Several questions remain concerning this model. First,
the fact that oligouridylated fragments of histone mRNA
are observed (Mullen and Marzluff 2008) does not indicate
whether 39 oligouridylation is an initiating and obligatory
step in histone mRNA degradation or a side reaction oc-
curring for preexisting degradation intermediates. Second,
the relative contributions of 59/39 and 39/59 degra-
dation are not known, nor whether decapping is a rate-
limiting step. Third, an oligo(U) tract promotes decapping
of an RNA substrate in vitro (Song and Kiledjian 2007), but
it is not known whether oligouridylation can also affect
mRNA stability in cultured cells if decapping is prevented.
Finally, translation of histone mRNA is required for its
degradation (Graves et al. 1987; Kaygun and Marzluff 2005),
but it is unclear whether it principally affects 59/39 or
39/59 pathways.
We have recently applied two technologies to study deg-
radation of polyadenylated mRNAs that may also provide
insight into SL-containing mRNAs. The first is the synthe-
sis of mRNAs in vitro with different structural features and
their introduction into mammalian cells by nucleopora-
tion (Grudzien-Nogalska et al. 2007a). The mRNAs are
incorporated into polysomes, efficiently translated within
15 min, and both their translation and degradation rates
are sensitive to the nature of the cap and the poly(A) tract.
The second is the development of cap analogs that cannot
be cleaved by the catalytic subunit of the human Dcp1-
Dcp2 decapping complex, hDcp2 (Grudzien-Nogalska et al.
2007b; Kowalska et al. 2008; Su et al. 2011). By blocking
59/39 degradation with a cleavage-resistant cap, one can
observe 39/59 degradation in isolation. We applied these
two technologies to achieve a better understanding of the
mechanisms governing the rapid destruction of histone
mRNAs when DNA synthesis ceases.
RESULTS
Decay of a polyadenylated reporter mRNA
is modulated by 59 and 39 structural elements
We synthesized mRNAs in vitro containing normal and
cleavage-resistant caps, different 59 UTRs, the coding re-
gion of firefly luciferase, and different 39 UTRs. These were
introduced into HeLa cells by nucleoporation, and the loss
of sequences over time was followed by qRT-PCR. We have
used this approach to introduce mRNAs into cultured mam-
malian cells previously and have validated the qRT-PCR
method of quantifying mRNA by two alternative methods:
Northern blotting and autoradiography of 32P-labeled mRNA
(Grudzien et al. 2006; Grudzien-Nogalska et al. 2007a; Su
et al. 2011). The ARCA (anti-reverse cap analog) (Fig. 1A)
has the same characteristics as the natural cap with respect
to translation and hydrolysis by hDcp2, but it has a mod-
ification at the C29 position of the m7Guo moiety to pre-
vent it from being incorporated into mRNA in the reverse
orientation by T7 polymerase (Stepinski et al. 2001; Jemielity
et al. 2003). mRNAs capped with the BTH analog (borano
two-headed) are more efficiently translated than those capped
with the ARCA and are completely resistant to hDcp2
hydrolysis in vitro (Su et al. 2011).
We recognize that there may be stability features in
endogenous mRNAs not present in exogenous reporter
mRNAs, which are never as stable as long-lived endogenous
mRNAs such as globin (Russell and Liebhaber 1996),
ovalbumin (Palmiter and Carey 1974), and casein (Guyette
et al. 1979). Furthermore, exogenous mRNAs do not go
through classical nuclear processing events, although it has
been demonstrated that nucleoporation delivers the ma-
jority of nucleic acids into the nucleus (Martinet et al. 2003;
Kurosawa et al. 2012). These differences may well result
in differences in the pathways utilized for degradation of
endogenous versus exogenous mRNAs. We, therefore, tested
several characteristics of exogenous mRNA decay in an
attempt to validate its physiological relevance.
We inserted the AU-rich element (ARE) of granulocyte-
macrophage colony-stimulating factor (GM-CSF) mRNA
(Chen et al. 1995) into the 39 UTR of Luc mRNA con-
taining a 60-nt poly(A) tract (ARCA-Luc-A60) to generate
ARCA-Luc-ARE-A60 (Fig. 1B). AREs are known to accel-
erate the degradation of endogenous c-Fos and GM-CSF
mRNAs by causing poly(A) shortening (Shaw and Kamen
1986; Chen and Shyu 1995). mRNA loss was measured with
a primer set that amplifies nt 1082–1171 (Fig. 1B, bars).
The decay pattern for ARCA-Luc-A60 was biphasic, con-
sisting of a lag phase of 9 6 3 min, followed by a rapid-
decay phase with t½ = 33.6 6 0.5 min (Fig. 1G, open
symbols; Table 1, line 1). The introduction of the ARE
destabilized the mRNA (Fig. 1G, filled symbols); the lag
phase disappeared, the t½ was reduced to 15.4 6 2.0 min,
and the relative translational efficiency was decreased to
0.7 6 0.1 (Table 1, lines 1,2). This indicates that the mRNA
degradation machinery triggered by an ARE is operational for
the exogenous mRNA. The fact that ARCA-Luc-ARE-A60 is
translated (Table 1) agrees with the known requirement for
ARE-accelerated degradation (Curatola et al. 1995).
When we introduced ARCA-Luc-A60 and BTH-Luc-A60
into HeLa cells, both underwent biphasic decay (Fig. 1H),
but the lag phase was greatly extended for BTH-Luc-A60
(51 6 4 min) compared to ARCA-Luc-A60 (9 6 3 min)
(Table 1, lines 1,3). The t½ values for the rapid-decay phase,
however, were statistically the same (31.0 6 9.0 versus
33.6 6 0.5 min). Since the BTH cap substantially stabilized
the mRNA, we conclude that decapping and 59/39
hydrolysis are important determinants of the decay rate
in our system. The eventual loss of BTH-Luc-A60 mRNA
(after the lag) could be due to 39/59 hydrolysis by the
exosome, loss of the cap by another decapping mechanism
that is not blocked by the BTH modification (Xiang et al.
2009; Jiao et al. 2010; Lu et al. 2011), or endonuclease
cleavage (Schoenberg 2011). These results indicate that
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FIGURE 1. Translation and decay of firefly luciferase (Luc) mRNA in HeLa cells. Luc mRNAs containing either a poly(A) tract (B,C) or the 39 UTR of
a human replicative histone (D) and either a normal cap (ARCA) or one that cannot be cleaved by hDcp2 (BTH) (A). (B) The AU-rich element (ARE)
of GM-CSF mRNA was inserted in the 39 UTR of ARCA-Luc-A60. Bars indicate a 90-nt sequence (nt 1082–1171) that is amplified during qRT-PCR
(total length of mRNA, 1773 nt; initiation codon at nt 37; termination codon at nt 1627). (C) Luc mRNAs with (lower diagram) and without (upper
diagram) a hairpin structure (HP13) in the 59 UTR. Bars in the upper diagram indicate a 190-nt sequence (nt 90–279) that is amplified during qRT-PCR
(total length of mRNA, 1763 nt; initiation codon at nt 37; termination codon at nt 1627). Bars in the lower diagram indicate a 190-nt sequence (nt 120–
309) that is amplified during qRT-PCR (total length of mRNA, 1793 nt; initiation codon at nt 67; termination codon at nt 1657). (D) Luc mRNAs with
a wild-type SL or mutated TL. Bars indicate a 190-nt sequence (nt 69–258) and 149-nt sequence (nt 1447–1595) that are amplified during qRT-PCR
with 59 and 39 primer sets, respectively (total length of mRNA, 1653 nt; initiation codon at nt 16; termination codon at nt 1606). (E,F) Luc activity
produced by introduction of the indicated mRNAs into HeLa cells by nucleoporation. Data are normalized for the amount of Luc mRNA present in the
cells as determined by qRT-PCR and averaged from at least two separate experiments for each transcript. (G–L) Decay pattern of in vitro-synthesized
Luc mRNAs in HeLa cells. Cells were lysed at the indicated times and 59 Luc sequences measured by qRT-PCR, except in G, where 39 sequences were
followed. In G, H, I, and K, the decay is biphasic and consists of a lag phase and rapid-decay phase. Vertical dashed lines mark the boundary between lag
and rapid-decay phases. The data for each transcript represent a single experiment, and error bars are for duplicate determinants at each time points.
When open circles and open triangles coincide, the former is shown on top. Average values from multiple experiments are given in Tables 1 and 2.
decapping is an early and important step in the decay of
polyadenylated mRNA in our system, as has been shown
for endogenous mRNAs (Coller and Parker 2004; Chen and
Shyu 2011).
A correlation between translation and stability of an
mRNA has been observed in numerous systems (Parker
and Sheth 2007). We tested the relationship between
translation and stability in this system by inserting a 13-bp
hairpin (HP13) into the 59 UTR of Luc-A50 mRNA (Fig. 1C,
lower diagram). This completely blocked translation of
both ARCA-HP13-LucA50 and BTH-HP13-LucA50 (Fig. 1E,
open symbols). The t½ of rapid-phase degradation was
shorter for ARCA-HP13-Luc-A50 (13.5 6 2.2 min) than for
ARCA-Luc-A50 (20.1 6 1.5 min) (cf. Fig. 1I and Fig. 1J,
open symbols; Table 1, lines 4,6). More strikingly, the lag
phases for both ARCA-Luc-A50 and BTH-Luc-A50 were
abolished by introduction of HP13 (Fig. 1J; Table 1, lines 4–7).
Despite the absence of a lag, BTH-HP13-Luc-A50 was de-
graded more slowly than ARCA-HP13-Luc-A50 (Fig. 1J, cf.
closed and open symbols; Table 1, lines 6,7).
This experiment suggests that the lag phase represents
the time that the mRNA is being translated and, hence,
protected from degradation. There is little effect of BTH on
the degradation of mRNAs that cannot be translated, sug-
gesting that decapping is no longer rate-limiting for such
mRNAs and that other processes which are normally re-
tarded by translating ribosomes (exosome, endonucleases)
become predominant. Overall, the dependence of the deg-
radation rate on translation is another indicator that our
reporter mRNAs mimic endogenous mRNAs.
The 39 SL is required for translation and stabilization
of a reporter mRNA
We utilized this experimental system but with a reporter
mRNA containing the 39 UTR of a human histone mRNA
(Luc-SL). We followed the loss of both 59 and 39 sequences
with different primer sets (Fig. 1D, bars) after introducing
mRNAs into synchronous S-phase HeLa cells. Both ARCA-
Luc-SL and BTH-Luc-SL decayed with biphasic kinetics
(Fig. 1K), but the lags for both 59 and 39 sequences of BTH-
Luc-SL (38.4 6 7.0 and 30.0 6 0.5 min, respectively) were
considerably longer than those of ARCA-Luc-SL (7.8 6 4.1
and 7.5 6 4.8 min, respectively) (Table 2, lines 1,11). The
loss of sequences during the rapid-decay phase was also
somewhat slower for BTH-Luc-SL (t½ = 30.2 6 2.4 and
21.5 6 1.5 min for 59 and 39 sequences, respectively) than
for ARCA-Luc-SL (t½ = 20.0 6 3.1 and 18.5 6 1.0 min,
respectively). Interestingly, the t½ for loss of 59 sequences of
BTH-Luc-SL was longer than for 59 sequences of ARCA-
Luc-SL (Table 2, lines 1,11), but it was the same for 59
sequences of ARCA-Luc-A50 and BTH-Luc-A50 (Table 1,
lines 4,5). This may result from different modes of decay
for SL-containing versus polyadenylated mRNAs.
Replacing the SL with a different tetra-loop (TL) struc-
ture prevents binding of histone mRNA to the SLBP and
inhibits translation (Gallie et al. 1996). A reporter mRNA
containing the TL (Fig. 1D, lower diagram) was similarly
inactive in translation (Fig. 1F, open symbols). The lag
phase was reduced from 7.8 6 4.1 min for ARCA-Luc-SL
to 0 min for ARCA-Luc-TL (cf. Fig. 1K and Fig. 1L, open
symbols; Table 2, lines 1,21), whereas the lag phase was
reduced from 38.4 6 7.0 min for BTH-Luc-SL to 10 6 0 min
for BTH-Luc-TL (cf. Fig. 1K and Fig. 1L, filled symbols;
Table 2, lines 11,22). Thus, as in the case of the HP13-Luc-
A50 mRNAs, decapping is a strong determinant in the
degradation of ARCA-Luc-SL (since failure to decap delays
degradation) but only for actively translated mRNAs. In the
absence of translation, other processes that are not retarded
by translation become dominant.
The SL is necessary and sufficient for mRNA
destabilization after inhibition of DNA
synthesis by hydroxyurea
Replication stress can be induced by treatment with the ri-
bonucleotide reductase inhibitor hydroxyurea (HU), which
halts S-phase progression (Ye et al. 2003). Endogenous
histone mRNAs are stable during S-phase (Harris et al.
1991), but HU treatment results in their rapid decay with
a t1/2 of z20 min (Sittman et al. 1983; Mullen and Marzluff
2008). We asked whether degradation of an SL-containing
mRNA is also accelerated by HU. In a preliminary experiment,
we demonstrated that synchronous HeLa cells continued to
progress through the cell cycle after nucleoporation, albeit
at a slower rate (Supplemental Fig. S1), and that DNA
synthesis dropped z50%, after which it slowly recovered
(Supplemental Fig. S2).
We introduced ARCA-Luc-SL and BTH-Luc-SL into
mid-S-phase HeLa cells (Fig. 2). HU added immediately
after nucleoporation accelerated the decay of both types of






No. mRNA (min) (min)
1 ARCA-Luc-A60 9 6 3 33.6 6 0.5 1
2 ARCA-Luc-ARE-A60 0 15.4 6 2.0 0.7 6 0.1
3 BTH-Luc-A60 51 6 4 31.0 6 9.0 N.D.
c
4 ARCA-Luc-A50 5 6 3 20.1 6 1.5 0.8 6 0.3
5 BTH-Luc-A50 30 6 10 20.0 6 1.8 1.4 6 0.3
6 ARCA-HP13-LucA50 0 13.5 6 2.2 0
7 BTH-HP13-LucA50 0 18.5 6 2.6 0
at½ was calculated from points between the end of the lag phase
and the last time point taken.
bTranslational efficiency was normalized to that of ARCA-Luc-A60.
cNot determined in the current work. The translational efficiencies
of BTH-Luc-A60 and nine other mRNAs in the A60 series were
reported in an earlier study (Su et al. 2011).
Su et al.
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mRNA (Fig. 2, open symbols), but the effect of HU was
greater on the loss of 39 sequences (Fig. 2B,D) than on 59
sequences (Fig. 2A,C). Furthermore, the lag phase for BTH-
Luc-SL was shortened by HU (Table 2, lines 11,12), and
this was more pronounced for 39 sequences (30.0 6 0.5
versus 10.0 6 5.0 min) than for 59 sequences (38.4 6 7.0
versus 23.5 6 5.0 min). For ARCA-Luc-SL, the lag phase
was completely eliminated by HU, both for 59 sequences
(Fig. 2A) and 39 sequences (Fig. 2B; Table 2, lines 1,2). The
predominant effect of HU on loss of 39 sequences is also
suggested by an analysis of t½ values for the rapid-
degradation phase. For ARCA-Luc-SL, where decapping
can occur and degradation is bidirectional (Mullen and
Marzluff 2008), HU shortens the t½ of both 59 (12.8 6 1.9
versus 20.0 6 3.1 min) and 39 sequences (12.5 6 0.8 versus
18.5 6 1.0 min) (Table 2, lines 1,2). However, for BTH-
Luc-SL, where decapping is prevented and degradation is
unidirectional, HU has little effect on the t½ of 59 sequences
(27.1 6 7.5 versus 30.2 6 2.4) but still shortens the t½ of 39
sequences (13.3 6 5.9 versus 21.5 6 1.5 min) (Table 2,
lines 11,12).
These results show that a reporter mRNA containing
only the 39 UTR of histone mRNA is destabilized by HU
similar to endogenous histone mRNA and that HU acts
mainly on the loss of 39 sequences. The findings are also
consistent with the previous report that knockdown of
exosome components stabilizes histone mRNA after HU
treatment more than knockdown of components involved
in the 59/39 pathway (Mullen and Marzluff 2008).
Degradation of Luc-SL mRNA involves decapping
by hDcp2
We interpret the observation that BTH-Luc-SL was stable
for z38 min (Table 2, line 11) whereas ARCA-Luc-SL was
stable for z8 min (Table 2, line 1) to mean that the lag phase
is related to the time required to decap the mRNA. When
decapping can occur (with ARCA-Luc-SL), it triggers 59/39
exonucleolytic hydrolysis (the rapid-phase decay). When
decapping cannot occur (with BTH-Luc-SL), the rapid-decay
phase is delayed, but the mRNA is eventually degraded by
other processes. However, just because BTH is resistant to
hDcp2 (Su et al. 2011), it does not mean that hDcp2 is
responsible for decapping of ARCA-Luc-SL, since there are
other mammalian decapping enzymes (Xiang et al. 2009;
Jiao et al. 2010; Lu et al. 2011). We, therefore, knocked
down hDcp2 in order to determine whether it was involved
in the decay of ARCA-Luc-SL.






Lag t1/2 Lag t1/2
1 ARCA-Luc-SL 7.8 6 4.1 20.0 6 3.1 7.5 6 4.8 18.5 6 1.0 1
2 ARCA-Luc-SL HU 0 12.8 6 1.9 0 12.5 6 0.8 N.D.
3 ARCA-Luc-SL hDcp2 KD 35.0 6 6.0 30.3 6 6.7 N.D.e N.D. N.D.
4 ARCA-Luc-SL TUTase 4 KD 8.0 6 2.0 30.3 6 1.1 8.0 6 2.0 26.9 6 4.7 N.D.
5 ARCA-Luc-SL TUTase 4 KD + HU 0 15.1 6 2.9 0 15.5 6 2.3 N.D.
6 ARCA-Luc-SL TUTase 3 KD 10.0 6 0 21.7 6 5.4 0 22.5 6 2.9 N.D.
7 ARCA-Luc-SL* 10.0 6 2.8 24.7 6 9.3 8.0 6 4.8 22.7 6 6.3 1.3 6 0.2
8 ARCA-Luc-SL* HU 10.0 6 0 17.0 6 0 20.0 6 0 19.8 6 2.0 N.D.
9 ARCA-Luc-SL-U10 0 18.5 6 1.9 0 20.6 6 0 0.7 6 0.1
10 ARCA-Luc-SL-U10* 0 14.6 6 1.0 0 20.5 6 1.0 0.5 6 0.1
11 BTH-Luc-SL 38.4 6 7.0 30.2 6 4.4 30.0 6 0.5 21.5 6 1.5 1.8 6 0.3
12 BTH-Luc-SL HU 23.5 6 5.0 27.1 6 7.5 10.0 6 5.0 13.3 6 5.9 N.D.
13 BTH-Luc-SL hDcp2 KD 45.0 6 5.0 41.8 6 1.8 N.D. N.D. N.D.
14 BTH-Luc-SL TUTase 4 KD 40.0 6 8.7 46.0 6 5.9 45.0 6 0 56.8 6 6.5 N.D.
15 BTH-Luc-SL TUTase 4 KD + HU 26.7 6 5.7 25.4 6 0.9 30.0 6 0 20.5 6 6.0 N.D.
16 BTH-Luc-SL TUTase 3 KD 20.0 6 0 21.3 6 4.5 20.0 6 0 23.2 6 1.8 N.D.
17 BTH-Luc-SL* 27.5 6 5.0 33.3 6 8.0 31.3 6 10.3 39.9 6 5.5 2.4 6 1.0
18 BTH-Luc-SL* HU 25.0 6 7.1 29.3 6 10.3 30.0 6 0 35.9 6 2.4 N.D.
19 BTH-Luc-SL-U10 20.0 6 5.0 18.1 6 0 10.0 6 5.0 21.4 6 0.5 0.8 6 0.2
20 BTH-Luc-SL-U10* 20.0 6 5.0 20.9 6 0 10.0 6 5.0 19.7 6 1.0 0.8 6 0.1
21 ARCA-Luc-TL 0 30.1 6 1.0 N.D. N.D. 0
22 BTH-Luc-TL 10 6 0 29.4 6 4.0 N.D. N.D. 0
amRNAs followed by an asterisk (*) were modified at the 39 end with cordycepin before nucleoporation.
bAs there was no significant difference for decay of Luc-SL mRNA in uninfected HeLa cells and HeLa cells that were infected with NT shRNAs,
statistics for Luc-SL mRNAs in untreated cells include experiments that were done in both cell types.
ct1/2 was calculated from two to six individual experiments. If there was a lag phase, the t½ was calculated for the post-lag period.
dTranslational efficiency was normalized to that of ARCA-Luc-SL.
eNot determined.
Oligouridylation accelerates decay of histone mRNA
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Infection of HeLa cells with a lentivirus expressing
a shRNA directed against the coding sequence of hDcp2
mRNA reduced hDcp2 mRNA levels to z20% of untreated
cells (Fig. 3A) and hDcp2 protein levels to z10% (Fig. 3B),
whereas a control nontarget (NT) shRNA had no effect.
ARCA-Luc-SL was more stable in hDcp2 knockdown cells
compared to NT cells (Fig. 3C). The lag phase was
elongated (35.0 6 6.0 versus 7.8 6 4.1 min) (Table 2, lines
1,3) as was the t½ of the rapid-decay phase (30.3 6 6.7
versus 20.0 6 3.1 min). In contrast, the
lag phases in knockdown and NT cells
for BTH-Luc-SL were statistically the
same (Fig. 3D), whereas the t½ of the
rapid-decay phase was longer in knock-
down than NT cells (41.8 6 1.8 versus
30.2 6 2.4) (Table 2, lines 11,13). These
results show that hDcp2 is involved in
decapping of ARCA-Luc-SL but has no
effect on BTH-Luc-SL. They also add
further support to the idea that the lag
phase reflects the time required for
initiation of decapping, since the lag
can be elongated by either the presence
of a BTH cap or by depletion of hDcp2.
Luc-SL mRNA is oligouridylated
during degradation
Fragments of histone mRNA with 39
oligo(U) tracts downstream from the
SL were found after treatment of cells
with HU (Mullen and Marzluff 2008), but
because this study examined steady-
state populations, it was not possible
to distinguish between oligouridylation being a rate-de-
termining step in histone mRNA degradation versus an
HU-induced side reaction, nor was it known whether
oligouridylation occurred prior to decapping. We, therefore,
asked whether Luc-SL was oligouridylated in our experi-
mental system and whether this was affected by HU or
decapping. We modified a previously published protocol for
RNA ligation-coupled RT-PCR (LC-RT-PCR) (Charlesworth
et al. 2004). Total RNAs extracted from cells after nucleo-
poration were ligated to a DNA linker termed P1 using
T4 RNA ligase (Fig. 4A). Two alternative primers were used
for reverse transcription. The OU1 primer is complementary
to P1, so all RNAs ligated to P1 are copied into cDNA. The
OU2 primer contains five A residues 39 to the sequence
complementary to P1, so only mRNAs that become ligated
to P1 and end in a 39 oligo(U) tract are copied. Our use of five
A residues avoided excessive false positives resulting from the
A tract being too short and a paucity of intermediates
resulting from the A tract being too long, since Lsm1–7 binds
to between five and 10 U residues (SM Lyons and WF
Marzluff, unpubl.). Quantitative PCR (qPCR) was then
performed using an upstream primer in the luciferase coding
region (Luc in Fig. 4A) and either OU1 or OU2 as the
downstream primer.
Sequences in ARCA-Luc-SL and BTH-Luc-SL amplified
with the OU1 primer decreased with time (Fig. 4B,C, filled
bars), and the decay of both mRNAs was accelerated by HU
(Fig. 4B,C, open bars). Sequences from both mRNAs were
also amplified with the OU2 primer, indicating some mole-
cules are oligouridylated, but they were much less abundant,
FIGURE 3. Decay of Luc-SL mRNA involves decapping by hDcp2. HeLa cells were infected
with lentiviruses expressing shRNA against hDcp2 or a nontarget shRNA (NT). (A) hDcp2
mRNA levels in uninfected (UN), NT, and hDcp2 KD cells. (B) Western blot of hDcp2 protein
levels in UN, NT, and hDcp2 KD cells. ARCA-Luc-SL (C) and BTH-Luc-SL (D) were
introduced into NT (filled symbols) or hDcp2 KD (open symbols) cells and the decay of 59
sequences followed over time. Error bars represent the results of duplicate experiments. When
error bars are not visible, they are smaller than the symbols.
FIGURE 2. Decay of Luc-SL mRNA is accelerated by HU treatment.
ARCA-Luc-SL (A,B) or BTH-Luc-SL (C,D) were introduced into syn-
chronous S-phase HeLa cells by nucleoporation, and the loss of 59 (A,C)
or 39 (B,D) sequences was followed by qRT-PCR. Some cells were treated
with HU immediately after nucleoporation (open symbols).
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only 1%–2% of the OU1 products (Fig. 4D,E; note difference
in y-axes). Unlike the OU1-amplified products, there was no
significant effect of HU on the amount of OU2-amplified
products of ARCA-Luc-SL (Fig. 4D) and only a marginal
effect on those of BTH-Luc-SL (Fig. 4E).
To examine the spectrum of products obtained by am-
plification of BTH-Luc-SL with OU1 and OU2 primers, we
included [a-32P]dATP in the PCR reaction and analyzed
the amplification products by polyacrylamide gel electro-
phoresis (PAGE) (Fig. 5A). The major product amplified
with the OU1 primer (Fig. 5A, lanes 3–14) consisted of a
cluster at 224, 229, and 233 nt, which is near the size
expected from full-length mRNA. The reason for the het-
erogeneity is not known; it could represent addition of
nontemplated nucleotide residues during synthesis of RNA
by T7 RNA polymerase (Milligan et al. 1987) or loss of
nucleotides downstream from the SL
(Ross et al. 1986). Similar results were
obtained with ARCA-Luc-SL (Supple-
mental Fig. S3).
In contrast to the LC-RT-PCR prod-
ucts obtained with the OU1 primer,
those obtained with the OU2 primer
were much less abundant and more
heterogeneous (Fig. 5A, lanes 17–28;
note difference in time of exposure in
the figure legend). Some of the bands
migrated faster than the major OU1
products, indicating that they were
shortened at the 39 end (since all prod-
ucts result from amplification with the
common Luc upstream primer). How-
ever, some bands migrated slower than
the major OU1 products, suggesting
that they were derived from the addi-
tion of relatively long oligo(U) tracts.
Similar OU2-amplified products were
observed with and without HU treat-
ment (Fig. 5A, cf. lanes 17–22 and
lanes 23–28), which is consistent with
the qRT-PCR results (Fig. 4D,E) and
indicates that oligouridylation occurs
in both HU-treated and untreated
cells.
We cloned a selection of LC-RT-PCR
products to determine their sequences.
The complete sequences of the 39 ends
of the RNAs are shown in Supplemental
Figure S4 and a schematic of the se-
quences, in Figure 5B–E. They represent
a mixture of full-length RNAs and those
lacking combinations of the SL (green),
the 39 UTR (orange), and the coding
region up to the location of the up-
stream Luc primer (dark gray). (Shorter
RNAs would not have been amplified because they lacked
the sequence complementary to the upstream primer.)
U-tracks were observed in all products (red). For ARCA-
Luc-SL, roughly half of the clones sequenced containing the
intact SL (Fig. 5B), in agreement with the nearly full-length
major band in Supplemental Figure S3, lanes 3–8. Treat-
ment with HU drastically reduced the number of SL-
containing sequences (Fig. 5D). For BTH-Luc-SL, there
were more long products containing the SL than for
ARCA-Luc-SL (cf. Fig. 5C and Fig. 5B), in agreement with
the quantitative data (cf. Fig. 4E and Fig. 4D). However,
fewer long sequences were detected after HU treatment
(Fig. 5E). There were relatively few OU2 products inter-
mediate in size between the nearly full-length SL-containing
RNAs and those that terminated near the upstream Luc
primer (Figs. 5B–E).
FIGURE 4. Detection of oligouridylation of Luc-SL mRNA by ligation-coupled RT-PCR
(LC-RT-PCR). (A) The LC-RT-PCR technique (see Materials and Methods). ARCA-Luc-
SL (B,D) or BTH-Luc-SL (C,E) were introduced into synchronous S-phase HeLa cells by
nucleoporation. RNAs were extracted, ligated to the P1 linker, amplified with either the
OU1 (B,C) or OU2 (D,E) primer, and quantified by qPCR. Some cultures were treated with
HU immediately after nucleoporation (open bars). Error bars represent duplicate
experiments.
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Degradation of Luc-SL mRNA is retarded
by knockdown of TUTase 4, but not TUTase 3,
in the absence of HU
TUTase 1 and 3 were implicated in the oligouridylation of
histone mRNA in one study (Mullen and Marzluff 2008),
but TUTase 4 was implicated in another (Schmidt et al.
2011). (See Supplemental Table S1 for alternative TUTase
names.) We, therefore, tested the effect of knocking down
TUTases 3 and 4 in our system. After selection of stable
cell lines with puromycin, we obtained 65% knockdown of
TUTase 3 mRNA (Supplemental Fig. S5A) and 70% knock-
down of TUTase 4 mRNA (Fig. 6A), whereas NT shRNA
had no effect.
Knockdown of TUTase 3 did not retard the loss of
sequences at either the 59 or 39 end of either ARCA-Luc-SL
or BTH-Luc-SL (Supplemental Fig. S5B–E; Table 2, lines
1,6,11,16). In contrast, TUTase 4 knockdown significantly
retarded the loss of sequences for both mRNAs in cells not
treated with HU. For ARCA-Luc-SL mRNA, the lag phases
for 59 and 39 sequences were not altered (8.0 6 2.0 versus
7.8 6 4.1 min and 8.0 6 2.0 versus 7.5 6 4.8 min,
respectively) (Fig. 6B; Table 2, lines 1,4), but the t½ of
the rapid-decay phase was lengthened (30.3 6 1.1 versus
20.0 6 3.1 min and 26.9 6 4.7 versus 18.5 6 1.0 min,
respectively). For BTH-Luc-SL mRNA, the lag phase for
59 sequences was not altered (40.0 6 8.7 versus 38.4 6
7.0 min) (Fig. 6C; Table 2, lines 11,14), but the t½ for the
rapid-decay phase was lengthened from 30.2 6 4.4 min to
46.0 6 5.9 min (Fig. 6E; Table 2, lines 11,14). For the 39
sequences of BTH-Luc-SL, TUTase 4 knockdown increased
the lag phase from 30.0 6 0.5 to 45.0 6 0 min (Fig. 6C)
and the t½ of the rapid-decay phase from 21.5 6 1.5 to
56.8 6 6.5 min, an increase of almost threefold (Fig. 6E;
Table 2, lines 11,14).
Interestingly, the gains in mRNA stability resulting from
TUTase 4 knockdown were prevented by addition of HU—
the lag phase for both 59 and 39 sequences of ARCA-Luc-
SL was abolished (Fig. 6B, asterisks) and t½ was reduced
(Fig. 6D; Table 2, lines 4,5). Similarly, for BTH-Luc-SL,
the lag phase for the loss of 59 sequences was shortened by
HU in both control cells (23.5 6 5.0 versus 38.4 6 7.0
min) and TUTase 4-knockdown cells (26.7 6 5.7 versus
40.0 6 8.7 min) (Fig. 6C), and the lengthening of the t½
(46.0 6 5.9 versus 30.2 6 4.4 min) was reversed by HU
treatment (25.4 6 0.9 min) (Fig. 6E; Table 2, lines
11,14,15). The dominant effect of HU over TUTase 4
knockdown is perhaps best seen in the loss of 39 sequences
of BTH-Luc-SL mRNA, where TUTase 4 knockdown
lengthens the rapid-phase t½ from 21.5 6 1.5 to 56.8 6
6.5 min, but the t½ is still decreased by HU (20.5 6 6.0
min) (Fig. 6E; Table 2, lines 11,14,15).
These results suggest that TUTase 4 plays an important
role in Luc-SL mRNA turnover in S-phase cells. The fact
that TUTase 4 knockdown stabilizes both ARCA-Luc-SL
and BTH-Luc-SL indicates that the TUTase 4-mediated
acceleration of 39/59 degradation does not require de-
capping. The observation that HU treatment abrogates the
effect of TUTase 4 knockdown suggests that accelerated
degradation of SL-containing mRNAs upon cessation of
DNA synthesis proceeds through a pathway that does not
involve TUTase 4.
FIGURE 5. Analysis of oligouridylated RNAs. (A) BTH-Luc-SL was
introduced into synchronous S-phase HeLa cells by nucleoporation
and amplified by LC-RT-PCR with either the OU1 (lanes 3–14) or
OU2 (lanes 17–28) primer except that [a-32P]dATP was included
during the PCR reaction. Cells were treated without (lanes 3–8, 17–22)
or with HU (lanes 9–14, 23–28). DNA markers are indicated as M
(lanes 1,30). LC-RT-PCR products from RNA isolated from HeLa
cells into which no Luc-SL mRNAs had been introduced are indicated
as N (lanes 2,16). PCR reactions that did not receive any cDNA
(nontemplate control) are indicated as C (lanes 15,29). The image
represents a single gel, but the left half was exposed to film for 16 h,
whereas the right half was exposed for 32 h. (B–E) LC-RT-PCR
products from RNAs isolated at the 30-min time point in A and
amplified with the OU2 primer were cloned and sequenced. The
actual sequences are shown in Supplemental Figure S4, and summa-
ries are shown for ARCA-Luc-SL (B,D) and BTH-Luc-SL (C,E). All
sequences contained an oligo(U) tract (red) and various combinations
of the SL (green), 39 UTR upstream of the SL (orange), and ORF
(dark gray).
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TUTase 4 knockdown causes accumulation of stalled
degradation products
To better understand the role of TUTase 4, we compared
the spectrum of LC-RT-PCR products after nucleopora-
tion of ARCA-Luc-SL or BTH-Luc-SL into cells express-
ing either NT or TUTase 4 shRNAs. For total products
amplified with the OU1 primer (Fig. 7A, lanes 3–18), the
major band in both sets of cells corresponded to an RNA of
231 nt, near the size expected from full-length RNA (Fig.
7A, open arrowhead). Oligouridylated products amplified
with the OU2 primer were still detected, despite the
TUTase 4 knockdown (Fig. 7A, lanes 27–34), the major
bands consisting of a doublet at 223 and 219 nt (filled
arrow). Both bands were more prominent and persisted
longer in TUTase 4 knockdown cells than in NT cells.
Cloning and sequencing of the LC-RT-PCR products
revealed that more RNAs contained the SL for BTH-Luc-SL
than ARCA-Luc-SL in TUTase 4 knockdown cells (cf.
Fig. 7C and Fig. 7B). Also, more contained the SL for BTH-
Luc-SL in TUTase 4 knockdown cells (Fig. 7C) than in
untreated cells (Fig. 5C), in agreement with the stronger
signals observed on the sequencing gel (Fig. 7A, cf. lanes
27–32 and lanes 19–26). This suggests that stalling of
39/59 degradation occurs more often at the SL/SLBP
complex when levels of TUTase 4 are reduced. Products
that contain full coding sequence but no 39 UTR were
observed only in TUTase 4 knockdown cells (Fig. 7; clones
#38, 43, 70, and 78) but not in uninfected cells (Fig. 5),
consistent with a model wherein 39/59 degradation stalls
more often at the termination codon when levels of TUTase
4 are reduced. We also observed oligouridylated products
in TUTase 3 knockdown cells (Fig. 7D) that were similar to
those in untreated cells (Fig. 5C).
Blocking the 39 end stabilizes histone mRNA
It is possible that 39 oligouridylation is one of a series of
sequential and obligatory steps in the degradation pathway,
but it is also possible that histone mRNA fragments are
produced by a pathway that does not involve oligouri-
dylation and are only subsequently oligouridylated. In the
first case, preventing oligouridylation should retard the rate
of Luc-SL degradation, whereas, in the second, it should
have no effect. To distinguish between these possibilities,
we synthesized SL-containing mRNAs with a chain termi-
nating nucleoside at the 39 end, namely, 39-deoxyadenosine
(cordycepin), to block addition of the 39 oligo(U) tract.
ARCA-Luc-SL was synthesized in vitro as in previous
experiments, but the 39 end was then blocked by adding
cordycepin with yeast poly(A) polymerase (PAP) (ARCA-
Luc-SL*). Performing a second PAP reaction on an aliquot
in the presence of [a-32P]ATP indicated that >95% of the
mRNAs were blocked (Supplemental Fig. S6A). When
introduced into HeLa cells by nucleoporation (Fig. 8A),
ARCA-Luc-SL* (filled symbols) decayed more slowly than
ARCA-Luc-SL (open symbols). The stabilization was more
apparent at later time points and for 39 sequences (Fig. 8A,
lower panel) than for 59 sequences (upper panel), suggest-
ing that oligouridylation affects the 39/59 pathway more
than the 59/39 pathway. BTH-Luc-SL* was also more
stable than BTH-Luc-SL (Fig. 8B), and again, this was
more pronounced at later time points and affected 39 more
than 59 sequences. For instance, the t½ for the rapid-decay
phase was lengthened from 21.5 6 1.5 to 39.9 6 5.5 min
for 39 sequences but only from 30.2 6 4.4 to 33.3 6 8.0 for
59 sequences (Table 2, lines 11,17). The fact that cordycepin
modification increased the stability of BTH-Luc-SL is
further evidence that oligouridylation primarily affects the
39/59 pathway; if it primarily affected the 59/39 path-
way, the cordycepin modification would not have changed
the decay kinetics, since BTH-Luc-SL cannot be decapped.
We interpret the increased stability that is achieved by
cordycepin modification as resulting from prevention of
oligouridylation, but it is possible that cordycepin modifi-
cation interferes with some other step that does not involve
oligouridylation, for instance, degradation by a 39/59
exonuclease that requires a free 39 OH. To rule this out,
we synthesized a preuridylated reporter mRNA by insert-
ing 10 T residues in the DNA template after the sequence
for Luc-SL, resulting in an mRNA that contains 10 U
FIGURE 6. Knocking down TUTase 4 stabilizes Luc-SL mRNA. HeLa
cells were infected with lentiviruses expressing an shRNA against
TUTase 4 or a NT shRNA. (A) TUTase 4 mRNA level in uninfected
(UN), NT, and TUTase 4 KD cells. The length of the lag phase (B,C)
and t½ (D,E) for decay of 59 and 39 sequence of ARCA-Luc-SL (B,D)
and BTH-Luc-SL (C,E) was measured by qRT-PCR in NT and
TUTase 4 KD (T4) cells for cells treated (+) or not treated () with
HU. Asterisks indicate no lag was detected.
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residues located 39 from the SL. Both ARCA-Luc-SL-U10
and BTH-Luc-SL-U10 were synthesized, and each was
modified with cordycepin to produce ARCA-Luc-SL-
U10* and BTH-Luc-SL-U10*, respectively. If 39 oligouri-
dylation increases the rate of mRNA degradation, the
preuridylated mRNAs will not be affected when additional
oligouridylation is prevented by cordycepin modification.
ARCA-Luc-SL-U10 had no lag phase and similar t1/2 for
rapid decay as ARCA-Luc-SL (cf. Fig. 8C and Fig. 8A,
open symbols; Table 2, lines 1,9), but cordycepin did not
diminish the degradation rate of ARCA-Luc-SL-U10 (Fig.
8C, cf. filled and open symbols). For BTH-Luc-SL-U10,
a shorter lag phase was observed compared to BTH-
Luc-SL (cf. Fig. 8D and Fig. 8B, open symbols). Since
59/39 degradation is blocked for this
mRNA, we interpret this to mean that
preuridylation accelerates the rate of
39/59 degradation, something we
cannot observe with ARCA-Luc-SL-
U10 because 59/39 degradation is so
fast. Importantly, however, cordycepin
incorporation did not affect the rate at
which either 59 or 39 sequence was lost
from BTH-Luc-SL-U10 mRNAs (Fig. 8D;
Table 2, lines 19,20). These results indi-
cate that oligouridylation per se acceler-
ates the rate of decay and not some other
process that is blocked by cordycepin
modification.
Because HU does not appear to de-
stabilize SL-containing mRNAs through
a pathway involving TUTase 4 (Fig. 6),
we expected that cordycepin-modified
mRNA would still be destabilized by
HU. Surprisingly, we found just the
opposite. For BTH-Luc-SL*, HU treat-
ment had no effect on the rate of loss of
either 59 or 39 sequences or either the
lag phase or the rapid-decay phase (cf.
Fig. 8F and Fig. 8B, filled symbols; Table
2, lines 17,18). This was also true for
ARCA-Luc-SL* (cf. Fig. 8E and Fig. 8A,
filled symbols). In fact, the lag phase for
decay of 39 sequences was actually length-
ened by HU (20.0 6 0 versus 8.0 6 4.8
min) (Table 2, lines 7,8). These results
indicate that destabilization of Luc-SL
mRNAs by HU treatment occurs through
a pathway that involves oligouridylation,
since inhibition of oligouridylation by
cordycepin prevents the action of HU.
The implication is that there are enzymes
in addition to TUTase 4 that oligouri-
dylate Luc-SL mRNAs.
To ensure that 39 addition of a cordy-
cepin to mRNA did not impair its ability to program protein
synthesis, we compared the translational efficiency in HeLa
cells of ARCA-Luc-SL to ARCA-Luc-SL* as well as BTH-
Luc-SL to BTH-Luc-SL* and found cordycepin modification
had no effect (Supplemental Fig. S6B; Table 2, lines 1,7,11,17).
Interestingly, we observed that translational efficiencies for
ARCA-Luc-SL-U10 and BTH-Luc-SL-U10 were approxi-
mately half those of their unmodified counterparts (Sup-
plemental Fig. S6C; Table 2, lines 1,9,11,19). However,
incorporation of cordycepin did not alter their translational
efficiencies (Supplemental Fig. S6C; Table 2, lines 9,10,
19,20). The diminished translation of preuridylated mRNAs
may be due to interference in the SL-SLBP interaction by
proteins that bind to oligo(U), such as Lsm1–7, which are
FIGURE 7. Analysis of LC-RT-PCR products of Luc-SL mRNAs in TUTase knockdown (KD)
cells. (A) LC-RT-PCR products derived from the degradation of BTH-Luc-SL were analyzed as
in Figure 5 except that TUTase 4 KD cells (lanes 11–18, 27–34) or NT cells (lanes 3–10, 19–26)
were used. The open arrow shows the position of the major OU1 product, while the filled arrow
shows the position of the major OU2 product. DNA markers are indicated as M (lanes 1,36). The
image represents a single gel, but the left half was exposed to film for 7 h, whereas the right half
was exposed for 70 h. (B–E) Summary of LC-RT-PCR sequences as in Figure 5.
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also known to recruit inhibitors of translation (Coller and
Parker 2005).
DISCUSSION
Previous studies have suggested that histone mRNA deg-
radation is initiated by oligouridylation at the 39 end
followed by decapping and 59/39 exonuclease degradation
and, at least on some molecules, by 39/59 degradation by
the exosome (Mullen and Marzluff 2008). Early reports
suggested that histone mRNA degrada-
tion occurs by a 39/59 pathway after
inhibition of DNA synthesis (Ross et al.
1986, 1987). In mammalian cell extracts,
degradation of polyadenylated mRNAs
occurs primarily 39/59 (Mukherjee
et al. 2002), although the contribution
of the two pathways in vivo is not well
understood. For degradation of his-
tone mRNA, it is not known whether
oligouridylation is essential for degra-
dation or to what extent decapping
plays a role in histone mRNA degra-
dation. It is also not known whether
degradation initiated by oligouridylation
is important only for the rapid deg-
radation that occurs when DNA repli-
cation is inhibited and at the end of
S-phase, or whether oligouridylation
is also involved in degradation during
S-phase when histone mRNA is rela-
tively stable. Our studies here, by in-
troducing into cells RNAs that have
been chemically modified to either pre-
vent decapping, prevent oligouridyla-
tion, or bypass the need for oligouri-
dylation by preuridylation, provide new
insights into the histone mRNA deg-
radation process in intact cells. Both
decapping and 39/59 degradation play
important quantitative roles in his-
tone SL-containing mRNA turnover,
not only in S-phase but also when DNA
synthesis is inhibited. When modifica-
tion of the 39 end of histone SL-con-
taining mRNA is prevented by addition
of cordycepin, degradation is slowed,
indicating that modification of the 39
end is a critical feature of histone SL-
containing mRNA degradation. Intro-
duction of a preuridylated histone SL-
containing mRNA (with or without
cordycepin blocking the 39 end) desta-
bilized the mRNA, indicating the im-
portance of the oligouridylation reac-
tion for both pathways. Finally, histone SL-containing
mRNAs are oligouridylated in S-phase both before and
after treatment of cells with HU.
In earlier studies, we introduced polyadenylated mRNAs
into mammalian cells to evaluate the ability of different
cap analogs to support translation (Grudzien et al. 2006;
Grudzien-Nogalska et al. 2007b; Su et al. 2011). Here, we
have similarly followed the fate of a reporter mRNA ending
in a histone SL. The reporter mRNA has a cap and the SL
that is essential for translation of histone mRNAs but
FIGURE 8. Blocking the 39 end of ARCA-Luc-SL and BTH-Luc-SL with the chain-terminator
cordycepin slows their degradation. (A) Loss of 59 and 39 sequences for ARCA-Luc-SL with
(filled symbols) or without (open symbols) cordycepin modification. (B) Same as A except that
BTH-Luc-SL was introduced. (C) Same as A except the ARCA-Luc-SL was synthesized in vitro
to contain a 39 (U)10 tract. (D) Same as C except BTH-Luc-SL-U10 was introduced. Addition of
HU immediately after nucleoporation destabilized ARCA-Luc-SL (E) and BTH-Luc-SL (F)
(open symbols) but did not destabilize these RNAs if they were first modified with cordycepin
(filled symbols).
Oligouridylation accelerates decay of histone mRNA
www.rnajournal.org 11
differs from endogenous histone mRNAs in two significant
ways: the ORF is Luc rather than histone, and the reporter
mRNA does not have a ‘‘nuclear history’’ (Kitamura et al.
1998), which can affect the cytoplasmic function of an
mRNA. However, several observations support the idea
that the metabolism of SL-containing reporter mRNAs
occurs by pathways shared with endogenous histone
mRNAs. First, the SL confers efficient translation to Luc-
SL mRNA (Fig. 1F), which indicates it binds SLBP
(Williams et al. 1994; Gallie et al. 1996; Sanchez and
Marzluff 2002). Second, Luc-SL mRNA is destabilized by
HU (Fig. 2A–D), as are endogenous histone mRNAs
(Pandey and Marzluff 1987). Third, degradation interme-
diates of Luc-SL mRNAs are found with 39 oligo(U) tracts
(Figs. 5, 7), as are those of endogenous histone mRNAs
(Mullen and Marzluff 2008).
The use of an exogenous reporter mRNA affords sev-
eral experimental advantages that cannot be realized with
plasmids expressing histone mRNAs. One can study the
kinetics of mRNA decay without ongoing synthesis as an
interfering factor. One can modify mRNAs at the 59 or 39
termini with cap analogs or chain-terminating 39 nucleo-
side residues. One can alter translational efficiency of the
mRNA and determine how it affects decay. Finally, one
can follow the degradation of a homogenous cohort of
initial intact mRNA molecules rather than a mixture of
intermediates.
Translation and degradation of the Luc-SL mRNA
These experiments provide insight into how the trans-
lational state of Luc-SL affects the rate and modes of
degradation. Initial studies suggested that the first detect-
able step in human H4 histone mRNA decay occurs at the
39 terminus and that degradation proceeds mainly in the
39/59 direction (Ross et al. 1986). More recently, histone
mRNAs were shown to be degraded by both 59/39 and
39/59 pathways (Mullen and Marzluff 2008), and de-
tection of histone mRNA fragments missing both 59 and 39
sequences indicated that degradation could occur bidirec-
tionally on the same molecule (Mullen and Marzluff 2008).
However, it was not clear which pathway is predominant.
The requirement for deadenylation of polyadenylated
mRNAs as a prerequisite for decapping provides a pre-
cedent for events at the 39 end affecting 59/39 degradation
(Muhlrad et al. 1994).
Histone and poly(A)-containing mRNAs introduced by
nucleoporation are translated and are initially relatively
stable, but then they enter a rapid phase of degradation
(Fig. 1). We interpret the lag phase as the time prior to
initiation of decapping, whereas the rapid-decay phase
reflects cessation of translation as a result of initial events
in degradation. We found that the lag preceding the ini-
tiation of rapid-phase degradation increases from z10 to
z40 min when a normal cap (ARCA-Luc-SL) is replaced
with an uncleavable one (BTH-Luc-SL), consistent with
decapping being important for governing the overall rate
of Luc-SL mRNA degradation. BTH-Luc-SL is translated
longer than ARCA-Luc-SL but still eventually enters a rapid-
decay pathway, likely the 39/59 pathway.
When translation is prevented by mutation of the SL
to TL, there is rapid degradation, suggesting that when
exogenous mRNAs are introduced into cells but not
translated, they are rapidly degraded. The lag either dis-
appears completely (in the case of ARCA-Luc-TL) or is
shortened (in the case of BTH-Luc-TL). We interpret this
to mean that the mRNA is protected from degradation
when it is translated, possibly because circularization blocks
access of the exosome, thereby preventing the activation
of decapping (Coller and Parker 2005).
Oligouridylation of histone mRNA
Oligouridylation of histone mRNAs occurs during S-phase
upon HU treatment (Mullen and Marzluff 2008), but the
mechanism and role of oligouridylation in histone mRNA
degradation is not well understood. Our data indicate that the
SL alone is necessary and sufficient to trigger oligouridylation,
independent of the nature of the ORF, and that oligouri-
dylation accelerates degradation. Preventing oligouridylation
by blocking the 39 end of the mRNA with cordycepin
stabilized Luc-SL. Coupling that modification with the
BTH cap analog resulted in even greater stabilization of
the mRNA under normal conditions and also prevented the
acceleration of degradation resulting from HU treatment.
This result is consistent with oligouridylation being an
important step for rapid degradation after HU treatment.
Oligouridylation is required for both 59/39 and 39/59
degradation. After HU treatment, there is a substantial de-
crease (30 to 10 min) in the lag phase for the loss of 39
sequences in BTH-Luc-SL, suggesting that the 39/59 path-
way becomes particularly important after HU treatment.
The TUTase involved in oligouridylation of histone
mRNA has not been definitively identified. One group
reported that knocking down TUTase1 or TUTase 3 slowed
histone mRNA degradation (Mullen and Marzluff 2008),
while another found this for TUTase 4 (Schmidt et al.
2011). The effect of TUTase 1 knockdown has since been
shown to result from an effect on cell growth (PE Lackey,
MK Slevin, and WF Marzluff, unpubl.). Here, we found
that knockdown of TUTase 4 slowed the degradation of
Luc-SL mRNA during normal S-phase progression, sug-
gesting that it plays a role in this pathway. However,
knockdown of TUTase 4 did not affect the increased
degradation of the Luc-SL mRNA that results from HU
treatment, suggesting that cell-cycle regulated degradation
may occur by a different pathway, possibly involving a
different TUTase.
We detected oligouridylated intermediates from Luc-
SL mRNAs in both control and TUTase 4 knockdown
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cells. Cloning of LC-RT-PCR products indicated that
the RNAs had oligo(U) tracts added at multiple sites,
with the majority at or near the SL. Many of the RNAs
had undergone partial degradation into the SL (likely
as a result of 39/59 exonuclease activity) and had
oligo(U) added at various places in the SL. We inter-
pret these findings to indicate exonuclease stalling and
oligouridylation ‘‘repriming’’ for the continued degra-
dation of the mRNA, as previously suggested (Mullen
and Marzluff 2008). The occurrence of reuridylation is
plausible since an initial round of 39/59 degradation
may be stalled by RNA secondary structure or proteins
bound to the RNA, leading to dissociation of degrada-
tion machinery; another round of oligouridylation would
be needed to recruit the machinery again and reinitiate
the degradation process. Different TUTases may be
needed for initial and reoligouridylation, and knocking
them down may have different effects on the rate of
decay. Finally, the fact that the pattern of oligouridylated
products was the same for BTH-Luc-SL and ARCA-Luc-
SL indicates that oligouridylation is not dependent on
prior decapping.
Blocking the 39 end stabilizes Luc-SL
It is well established that cordycepin terminates RNA
synthesis when incorporated by RNA polymerase and
polyadenylation when incorporated by poly(A) polymerase
(Horowitz et al. 1976; Muller et al. 1977). It will also
prevent oligouridylation, regardless of which TUTases
are responsible, and here, we find that it slows Luc-SL
degradation. This provides evidence that oligouridylation
is an obligatory step in Luc-SL degradation. The fact that
we observe oligouridylated products in cells that are not
treated with HU indicates that cessation of DNA synthesis
is not a requirement for oligouridylation. Yet, even when
decapping is blocked by an uncleavable cap and 39
oligouridylation is blocked by cordycepin, BTH-Luc-SL*
is still ultimately degraded, albeit at a slower rate. This may
be due to endonucleolytic cleavage or enzymes capable of
removing the BTH cap. Consistent with the observation
that blocking oligouridylation stabilizes Luc-SL, we find
that providing a preuridylated mRNA accelerates Luc-SL
degradation. Thus oligouridylation is likely the rate-limiting
step for histone mRNA degradation.
Besides the insights into the mechanism of mRNA deg-
radation provided by the cordycepin modification, there
are potential practical applications. In vitro-synthesized
mRNAs encoding tumor antigens can be used to elicit an
immune response in dendritic cells, and vaccination with
such mRNAs has already entered clinical testing for the
treatment of cancer (Weide et al. 2008; Diken et al. 2011).
The use of a cleavage-resistant cap increases mRNA sta-
bility and translational efficiency of exogenous mRNA in
mice and enhances priming and expansion of naive
antigen-specific T-cells (Kuhn et al. 2010, 2011). In
Saccharomyces pombe, oligouridylation of poly(A)-contain-
ing mRNA by the noncanonical poly(A) polymerase Cid1
has been demonstrated (Rissland and Norbury 2008, 2009).
In preliminary experiments, we have observed that poly-
adenylated reporter mRNAs are also stabilized by cordycepin
modification when introduced into HeLa cells (W Su and
RE Rhoads, unpubl.). We, therefore, speculate that such an
mRNA would have improved stability and translational
efficiency in mice, thus enhancing the immune response.
MATERIALS AND METHODS
Materials
All common reagents were of analytical grade. ARCA and BTH
cap analogs were synthesized as previously described (Jemielity
et al. 2003; Su et al. 2011).
In vitro synthesis of mRNA
pLuc-A60 was constructed as previously described (Grudzien et al.
2006). pT7-Luc-ARE-A60 was constructed by inserting an ARE
(Fig. 1B; Chen et al. 1995) into the 39 UTR of Luc-A60 at the
BamHI site immediately upstream of the poly(A) tract. pT7-Luc-
SL and pT7-Luc-TL were constructed and linearized as previously
described (Gallie et al. 1996; Ling et al. 2002). pT7-Luc-A50 and
pT7-HP13-Luc-A50 (Niepel et al. 1999) were generously provided
by Daniel Gallie (University of California, Riverside). The linear-
ized plasmids served as templates for in vitro synthesis of mRNAs
as previously described (Su et al. 2011).
Lentiviral shRNA transduction
Plasmids for construction of lentiviruses containing various
shRNAs were introduced into cells by either calcium-phosphate
(Kingston et al. 2003) or Lipofectamine 2000 (Invitrogen).
Plasmids encoding shRNA against hDcp2 were purchased from
Sigma (MISSION TRC shRNA, Sigma-Aldrich). pLKO1 plasmids
containing shRNA to TUTase 3 and 4 and lentiviral packaging
plasmids were obtained from the University of North Carolina
lenti-shRNA core. HeLa cells were infected with lentiviruses express-
ing shRNAs by using the shRNA targeting protocol (Sigma-Aldrich).
Infected cells were selected with 2 mg/mL puromycin 24 h post-
infection and kept in puromycin for at least 4 d prior to analysis.
Infecting with lentiviruses expressing shRNA against TUTase 3
and 4 resulted in 10% and 30% survival of HeLa cells, respectively.
Cell culture and nucleoporation
HeLa cells were cultured as previously described (Su et al. 2011).
Asynchronous cells were seeded 1 d prior to nucleoporation onto
150-mm dishes at a density such that cells would reach 70%
confluency the next day. Cells for synchronization (1 3 106) were
seeded onto 150-mm dishes and synchronized by double-thymi-
dine block (Jackman and O’Connor 2001). Cells were released
from double-thymidine block on the day of nucleoporation,
detached from plates 3 h after release (middle of S-phase), and
subjected to nucleoporation as described previously (Su et al. 2011).
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Measurement of translational efficiency and mRNA
decay in HeLa cells
For assay of translational efficiency in cultured cells, aliquots of
0.5 3 105 cells were shaken in 1.5-mL Eppendorf tubes at 37°C for
various times after nucleoporation. Total protein was extracted
and luciferase activity measured and normalized to the amount of
luciferase mRNA delivered into the cell at 0-time, as described
previously (Grudzien-Nogalska et al. 2007a). For measurement of
mRNA stability over periods of <1 h, cells were shaken in
Eppendorf tubes as described above. For periods >1 h, cells were
plated onto 35-mm cell culture dishes and incubated at 37°C in
5% CO2. The extraction of total RNA was performed as described
previously (Grudzien-Nogalska et al. 2007a). Luciferase mRNA
was quantified by qRT-PCR by using primers designed with the
Beacon Designer tool (Bio-Rad). Sequences from the 59 end of Luc
mRNA were amplified with 59-GGATGGAACCGCTGGAGAG-39
and 59-GCATACGACGATTCTGTGATTTG-39. Sequences from
the 39 end of Luc mRNA were amplified with 59-ATCGTGGAT
TACGTCGCCAGTCAA-39 and 59-TTTCCGCCCTTCTTGGCC
TTTATG-39. Human 18S rRNA levels were measured by the
same method and in the same RNA samples with primers
59-CGAGCCGCCTGGATACC-39 and 59-CAGTTCCGAAAACC
AACAAAATAGA-39. Amplification and detection were per-
formed with the iCycler IQ real time PCR detection system in
25-mL reaction mixtures containing 5 mL of the transcription
reaction mixture (50 ng of cDNA), 12.5 mL of IQ SYBRgreen
Supermix, and 0.3 mM primers (Bio-Rad). The incubation
conditions consisted of 3 min at 95°C for polymerase activation
and 40 cycles, each of 15 sec at 95°C and 1 min at 60°C. Luciferase
mRNA levels were calculated using the absolute standard curve
method as described in User Bulletin No. 2 for the ABI Prism 7700
Sequence Detection System. Luciferase mRNA was then normal-
ized for the amount of 18S rRNA in each sample, an indicator of
total cellular RNA purified from each cell extract. KaleidaGraph
(version 3.06, Synergy Software) was used for nonlinear least-
squares fitting of decay data.
LC-RT-PCR and PAGE
LC-RT-PCR was performed as described (Charlesworth et al.
2004) but with modifications. The reaction mixture (10 mL)
contained 1 mg of total RNA, 50 mM P1 linker [59-(Phos)
GGTCACCTTGATCTGAAGC(AmC7-Q)-39] (MWG-Operon),
1 mL of T4 RNA ligase (New England Biolabs), and 13 ligation
buffer. RNA and the P1 linker were heated to 65°C for 10 min,
cooled on ice for 2 min prior to addition of T4 RNA ligase,
incubated at 37°C for 30 min, and treated at 65°C for 15 min to
inactivate the enzyme. The reverse transcription reaction mixture
(5 mL), containing 2 mL of ligated RNA, 1 mL of specific primer
(10 mM), and 0.2 mL of 10 mM dNTPs, was heated at 65°C for
5 min and cooled on ice for 2 min, after which 0.5 mL of 0.1 M
DTT, 2 mL of 53 first strand buffer (Invitrogen), and Superscript
III reverse transcriptase (Invitrogen) were added in a final volume
of 10 mL. Two specific primers, OU1 and OU2, were utilized for
reverse transcription separately (Fig. 4A). For some reactions,
PCR products were labeled in a 25-mL reaction containing 1 mL of
cDNA, 2.5 mL of Platinum PCR reaction buffer, 0.75 mL of 50 mM
MgCl2, 0.5 mL of 10 mM dNTPs, 0.5 mL of 10 mM upstream Luc
primer (59-ATCGTGGATTACGTCGCCAGTCAA-39), 0.5 mL of
either 10 mM OU1 or OU2 primer, 0.5 mL of [a-32P]dATP, and
0.1 mL Platinum Taq Polymerase (Invitrogen). The PCR reaction
was performed by 35 cycles at 94°C for 30 sec, 55.1°C for 1 min,
and 72°C for 1 min. 32P-labeled PCR products were analyzed by
PAGE as described previously (Su et al. 2011), except that the gel
contained 8% polyacrylamide and 8 M urea. DNA markers were
prepared by labeling an ultra low range DNA ladder (10–300 bp)
(Fisher Scientific) with T4 polynucleotide kinase and [g-32P]ATP
by the exchange protocol as described by the manufacturer.
Cloning and sequencing of LC-RT-PCR products
LC-RT-PCR products (1 mL) were inserted into the TOPO vector
according to the manufacturer’s protocol (Invitrogen). Colonies
were screened by colony hybridization using radiolabeled probes
(Sambrook et al. 1989). Plasmids with Luc-SL inserts were
sequenced at Iowa State University.
Cordycepin incorporation
Incorporation of cordycepin was performed in a 100-mL reaction
mixture that contained 0.2 mM ARCA-Luc-SL or BTH-Luc-SL,
13 PAP reaction buffer (Affymetrix), 100 mM cordycepin
59-triphosphate (Sigma), 1 unit/mL of RNase Inhibitor (Ap-
plied Biosystems), and 2400 units of yeast PAP (Affymetrix). The
reaction mixture was incubated at 37°C for 1 h. RNAs were
precipitated by adding two volumes of Precipitation/Inactivation
buffer (Ambion), kept at 20°C for at least 1 h, collected by cen-
trifugation at 13,000g at 4°C for 20 min, and dissolved in 30 mL of
DEPC-treated water. The RNA concentration was determined by
UV absorbance at 260 nm, and RNA integrity was verified by
electrophoresis on 1.2% agarose gels containing formaldehyde.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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